Concepedia

Author

Paul Ardayfio

Eli Lilly (United States)

Also Known As

P ARDAYFIO, P Ardayfio, P. Ardayfio, P., Ardayfio, P.A. Ardayfio, Paul A Ardayfio, Paul A. Ardayfio, Paul Ardayfio, Rasha Almubark

40

Publications

4.8K

Citations

18

H-Index

39

Concepts

All Affiliations

Eli Lilly (United States)Harvard UniversityButler HospitalMcLean HospitalBrown University
PA

About

Paul Ardayfio is an author at Eli Lilly (United States) specializing in medicine, pharmacology, and neuroscience.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

258

2

Social Sciences

3

3

188

3

Health Sciences

2

2

78

4

Endocrinology

2

2

131

5

Cognitive Science

1

1

49

Paul Ardayfio

×

22

Publications

4.7K

Citations

17

H-Index

YearCitations

Donanemab in Early Symptomatic Alzheimer Disease

John R. Sims, Jennifer A. Zimmer, Cynthia Evans,

JAMA

2023

2.2K

Donanemab in Early Alzheimer’s Disease

Mark A. Mintun, Albert Lo, Cynthia Evans,

New England Journal of Medicine

2021

1.5K

3,4-Dihydroxyphenylalanine Reverses the Motor Deficits in Pitx3-Deficient<i>Aphakia</i>Mice: Behavioral Characterization of a Novel Genetic Model of Parkinson's Disease

Dong‐Youn Hwang, Sheila M. Fleming, Paul Ardayfio,

Journal of Neuroscience

2005

172

Anxiogenic-like effect of chronic corticosterone in the light-dark emergence task in mice.

Paul Ardayfio, Kwang‐Soo Kim

Behavioral Neuroscience

2006

121

Donanemab (LY3002813) dose‐escalation study in Alzheimer's disease

Stephen L. Lowe, Brian A. Willis, Anne Hawdon,

Alzheimer s & Dementia Translational Research & Clinical Interventions

2021

114

Donanemab (LY3002813) Phase 1b Study in Alzheimer's Disease: Rapid and Sustained Reduction of Brain Amyloid Measured by Florbetapir F18 Imaging

Stephen L. Lowe, Cynthia Evans, Sergey Shcherbinin,

The Journal of Prevention of Alzheimer s Disease

2021

100

Preclinical Evaluation of Melanin-Concentrating Hormone Receptor 1 Antagonism for the Treatment of Obesity and Depression

Donald R. Gehlert, Kurt Rasmussen, Janice Shaw,

Journal of Pharmacology and Experimental Therapeutics

2009

78

Amyloid-Related Imaging Abnormalities With Donanemab in Early Symptomatic Alzheimer Disease

Jennifer A. Zimmer, Paul Ardayfio, Hong Wang,

JAMA Neurology

2025

65

Donanemab Population Pharmacokinetics, Amyloid Plaque Reduction, and Safety in Participants with Alzheimer's Disease

Ivelina Gueorguieva, Brian A. Willis, Laiyi Chua,

Clinical Pharmacology & Therapeutics

2023

64

Impaired learning and memory in Pitx3 deficient aphakia mice: A genetic model for striatum-dependent cognitive symptoms in Parkinson's disease

Paul Ardayfio, Jisook Moon, Ka Ka Amanda Leung,

Neurobiology of Disease

2008

49

Page 1